loader2
Partner With Us NRI

Company details

2.27
2.27
0.00
0.00
6M Return 0.00%
1Y Return 18.85%
Mkt Cap.(Cr) 1.58
Volume 13
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 13

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 5.17 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 1,077.60 36,508.33
LAST 3M 38,231.60 5,545.35
LAST 6M 121,291.29 -142,349.22
LAST 12M 212,636.06 -215,172.33

Information

  • About Company
  • Company Info
  • Listing Info
45.4
69.59%
1.2814
0.23%
0.28%
Description
  • Mardia Samyoung Capillary Tubes Company Ltd,, a Joint Venture between Mardia Group Companies i.e Mardia Extrusions & Mardia Tubes and Samyoung Jung Kwan Company of South Korea was incorporated in Oct 1992 and engaged in manufacture of capillary and thin-walled pipes and tubes made from brass, stainless steel, copper and other copper alloys. The foreign collaborator holds 25% stake in the company. The foreign collaborator Samyoung, S.Korea has agreed to buy 6000 tpa of the finished products of the company apart from providing financial and technical collaboration. The company`s manufacturing facility with an installed capacity of 1800 tpa is located in Silvassa. The company has tapped the capital market with an public issue in Feb 1994 to finance setting up of this Silvasa manufacturing facility. The small-diameter tubes manufactured by the company, are required for manufacturing ball pens and refills, internal antennae and articles, radiators, heat exchangers, fluorescent tubes, video cassette rollers and other components used in the electronic and automobile industries. They are also used for refrigeration and air-conditioning. The company was referred to BIFR during the year 1999 and ICICI was appointed as Operating Agency. The OA has appointed M/s Vikas Consultants to conduct complete Techno-Economic Feasibility study and the report has been duly submitted to ICICI and the comments thereon is still awaited(as on March 31, 2002). During the year 1999, the Company`s Net Worth has been fully eroded and the Company had been refered to BIFR, and the Board had appointed ICICI as the operating agency.The Techno-Economic Feasibility study was conducted by M/s Vikas Consultants which is not yet completed.

Read More

Registered Address

J-55 M I D C Industrial area, Tarapur Boisar, Thane, Maharashtra, 401506

Tel : 91-22-24969685
Email : mardiamail:hotmail.com

Registrar

Purva Sharegistry (India) Pvt

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 513544
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : Z
ISIN : INE277E01026

ICICIdirect Mardia Samyoung Capillary Tubes Company Ltd FAQ

You can buy Mardia Samyoung Capillary Tubes Company Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Mardia Samyoung Capillary Tubes Company Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 07, 2021 04:00 PM the closing price of Mardia Samyoung Capillary Tubes Company Ltd was ₹ 2.27.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jun 07, 2021 04:00 PM, the market cap of Mardia Samyoung Capillary Tubes Company Ltd stood at ₹ 1.58.
The latest PE ratio of Mardia Samyoung Capillary Tubes Company Ltd as of Jun 07, 2021 04:00 PM is 45.4
The latest PB ratio of Mardia Samyoung Capillary Tubes Company Ltd as of Jun 07, 2021 04:00 PM is 0.56
The 52-week high of Mardia Samyoung Capillary Tubes Company Ltd is ₹ 0 while the 52-week low is ₹ 0 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE